IPP Bureau

First clinical use of Lucent 3D Lumber successful
First clinical use of Lucent 3D Lumber successful

By IPP Bureau - November 09, 2021

The Lucent 3D Lumbar Interbody System features a functionally unique multi-component device manufactured in a 3D printing sequence

Amneal Pharmaceuticals acquires Puniska Healthcare for Rs 700 crore
Amneal Pharmaceuticals acquires Puniska Healthcare for Rs 700 crore

By IPP Bureau - November 09, 2021

The company has operations in North America, Asia, and Europe,

Pfizer’s Covid-19 drug a potential game changer
Pfizer’s Covid-19 drug a potential game changer

By IPP Bureau - November 08, 2021

In the overall study population through Day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo

Divis Labs PAT at Rs 606.46 cr. in Q2FY22
Divis Labs PAT at Rs 606.46 cr. in Q2FY22

By IPP Bureau - November 08, 2021

Divi's Laboratories Limited has reported consolidated financial results for the period ended September 30, 2021.

Lupin launches fenofibrate in the US
Lupin launches fenofibrate in the US

By IPP Bureau - November 08, 2021

The drug helps in managing cholesterol

Govt places orders for one crore doses of ZyCoV-D
Govt places orders for one crore doses of ZyCoV-D

By IPP Bureau - November 08, 2021

It is the world’s first DNA-based Covid vaccine

Meiji Seika Pharma to build new facility in Bangalore to expand CMO business
Meiji Seika Pharma to build new facility in Bangalore to expand CMO business

By IPP Bureau - November 08, 2021

The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23

UK authorises first Covid-19 pill
UK authorises first Covid-19 pill

By IPP Bureau - November 05, 2021

Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency

Novavax files emergency use listing with WHO for Covid-19 vaccine
Novavax files emergency use listing with WHO for Covid-19 vaccine

By IPP Bureau - November 05, 2021

All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO

CorporateServe launches PharmaSoft 2.0
CorporateServe launches PharmaSoft 2.0

By IPP Bureau - November 05, 2021

The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity

St. George’s University School of Medicine to host a webinar for aspiring doctors
St. George’s University School of Medicine to host a webinar for aspiring doctors

By IPP Bureau - November 05, 2021

The students can interact with resident doctors and graduates of SGU

Aster Medcity Kochi launches Cryo-ablation procedure to tackle heart disease
Aster Medcity Kochi launches Cryo-ablation procedure to tackle heart disease

By IPP Bureau - November 05, 2021

The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day

CIMS doctors perform heart transplant on 15-year-old in Ahmedabad
CIMS doctors perform heart transplant on 15-year-old in Ahmedabad

By IPP Bureau - November 05, 2021

The transplant procedure was completed in under two hours

Prime Therapeutics to list Semglee and Insulin Glargine
Prime Therapeutics to list Semglee and Insulin Glargine

By IPP Bureau - November 05, 2021

Biocon Biologics and Viatris co-developed the products

Shilpa Biologics permitted to conduct Phase 1 study on NavAlbumin
Shilpa Biologics permitted to conduct Phase 1 study on NavAlbumin

By IPP Bureau - November 05, 2021

The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent

Latest Stories

Interviews

Packaging